From the Division of Pediatric Surgery, Children's Hospital of Orange County, Orange, California.
Department of Surgery, University of California Irvine Medical Center, Orange, California.
ASAIO J. 2019 Jul;65(5):509-515. doi: 10.1097/MAT.0000000000000834.
Although the mortality of infants with congenital diaphragmatic hernia (CDH) has been improving since the late 1990s, this observation has not been paralleled among the CDH cohort receiving extracorporeal membrane oxygenation (ECMO). We sought to elucidate why the mortality rate in the CDH-ECMO population has remained at approximately 50% despite consistent progress in the field by examining the baseline risk profile/characteristics of neonates with CDH before ECMO (pre-ECMO). Neonates with a diagnosis of CDH were identified in the Extracorporeal Life Support Organization (ELSO) Registry from 1992 to 2015. Individual pre-ECMO risk score (RS) for mortality was categorized to pre-ECMO risk-stratified cohorts. Temporal trends based on individual-level mortality by risk cohorts were assessed by logistic regression. We identified 6,696 neonates with CDH. The mortality rates during this time period were approximately 50%. The average baseline pre-ECMO RS increased during this period: mean increase of 0.35 (95% confidence interval [CI]: 0.324-0.380). In the low-risk cohort, the likelihood of mortality increased over time: each 5 year change was associated with a 7.3% increased likelihood of mortality (odds ratio [OR]: 1.0726; 95% CI: 1.0060-1.1437). For the moderate-risk cohort, the likelihood of mortality decreased by 7.05% (OR: 0.9295; 95% CI: 0.8822-0.9793). There was no change in the odds of mortality for the high-risk cohort (OR: 0.9650; 95% CI: 0.8915-1.0446). Although the overall mortality rate remained approximately constant over time, the individual likelihood of death has declined over time in the moderate-risk cohort, increased in the low-risk cohort, and remained unchanged in the high-risk cohort.
尽管自 20 世纪 90 年代末以来,先天性膈疝(CDH)患儿的死亡率一直在提高,但在接受体外膜肺氧合(ECMO)治疗的 CDH 患者中并未出现这种情况。我们试图通过检查 ECMO 前(pre-ECMO)CDH 新生儿的基线风险概况/特征来阐明为什么尽管该领域不断取得进展,但 CDH-ECMO 人群的死亡率仍保持在约 50%。从 1992 年到 2015 年,在体外生命支持组织(ELSO)登记处确定了患有 CDH 的新生儿。个体 ECMO 前死亡率(RS)风险被归类为 ECMO 前风险分层队列。通过逻辑回归评估基于个体死亡率的时间趋势。我们确定了 6696 名患有 CDH 的新生儿。在此期间,死亡率约为 50%。在此期间,平均基线 pre-ECMO RS 增加:平均增加 0.35(95%置信区间[CI]:0.324-0.380)。在低风险队列中,死亡率随时间的增加而增加:每 5 年的变化与死亡率增加 7.3%相关(优势比[OR]:1.0726;95% CI:1.0060-1.1437)。对于中危队列,死亡率的可能性降低了 7.05%(OR:0.9295;95% CI:0.8822-0.9793)。高危队列的死亡率几率没有变化(OR:0.9650;95% CI:0.8915-1.0446)。尽管总体死亡率随时间保持大致不变,但中危队列中个体死亡的可能性随时间下降,低危队列中增加,高危队列中保持不变。